Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

840 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
Yee CS, Gordon C, Dostal C, Petera P, Dadoniene J, Griffiths B, Rozman B, Isenberg DA, Sturfelt G, Nived O, Turney JH, Venalis A, Adu D, Smolen JS, Emery P. Yee CS, et al. Among authors: isenberg da. Ann Rheum Dis. 2004 May;63(5):525-9. doi: 10.1136/ard.2002.003574. Ann Rheum Dis. 2004. PMID: 15082482 Free PMC article. Clinical Trial.
Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE.
Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, d'Ascanio A, Bombardieri S. Vitali C, et al. Among authors: isenberg da. Clin Exp Rheumatol. 1992 Sep-Oct;10(5):527-39. Clin Exp Rheumatol. 1992. PMID: 1458709 Review.
Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE.
Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Neri R, Bombardieri S. Vitali C, et al. Among authors: isenberg da. Clin Exp Rheumatol. 1992 Sep-Oct;10(5):541-7. Clin Exp Rheumatol. 1992. PMID: 1458710 Review.
Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE.
Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Bombardieri S. Bencivelli W, et al. Among authors: isenberg da. Clin Exp Rheumatol. 1992 Sep-Oct;10(5):549-54. Clin Exp Rheumatol. 1992. PMID: 1458711 Review.
Idiopathic myositis: a rheumatological view.
Ehrenstein MR, Snaith ML, Isenberg DA. Ehrenstein MR, et al. Among authors: isenberg da. Ann Rheum Dis. 1992 Jan;51(1):41-4. doi: 10.1136/ard.51.1.41. Ann Rheum Dis. 1992. PMID: 1540036 Free PMC article.
Antibodies to protein P in systemic lupus erythematosus.
Teh LS, Bedwell AE, Isenberg DA, Gordon C, Emery P, Charles PJ, Harper M, Amos N, Williams BD. Teh LS, et al. Among authors: isenberg da. Ann Rheum Dis. 1992 Apr;51(4):489-94. doi: 10.1136/ard.51.4.489. Ann Rheum Dis. 1992. PMID: 1586246 Free PMC article.
840 results